Showing results (1021-1030 of 1,136) with videos related to

Sort By:
Pageof 114
Trials|January 8, 2020
Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trialFiona Gaughran, Dominic Stringer, Michael Berk, et al.
JAMA Network Open|November 10, 2020
Effect of Sodium Benzoate vs Placebo Among Individuals With Early Psychosis: A Randomized Clinical TrialJames G Scott, Andrea Baker, Carmen C W Lim, et al.
The Australian and New Zealand Journal of Psychiatry|October 23, 2020
Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trialsRobson Zazula, Muhammad Ishrat Husain, Mohammadreza Mohebbi, et al.
Trials|June 6, 2019
A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependenceRebecca McKetin, Olivia M Dean, Alyna Turner, et al.
Acta Psychiatrica Scandinavica|November 29, 2023
Reduced mitochondrial respiratory capacity in patients with acute episodes of bipolar disorder: Could bipolar disorder be a state-dependent mitochondrial disease?Anna Giménez-Palomo, Mariona Guitart-Mampel, Ana Meseguer, et al.
The Australian and New Zealand Journal of Psychiatry|February 16, 2013
Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task ForceBenicio N Frey, Ana C Andreazza, Josselin Houenou, et al.
Bipolar Disorders|December 15, 2012
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, et al.
Drug and Alcohol Review|October 6, 2020
Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trialRebecca McKETIN, Brendan Quinn, Peter Higgs, et al.
The Lancet. Psychiatry|August 3, 2019
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trialChristopher G Davey, Andrew M Chanen, Sarah E Hetrick, et al.
Molecular Psychiatry|November 24, 2020
The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studiesWolfgang Marx, Amelia J McGuinness, Tetyana Rocks, et al.
Pageof 114